Linked Life Data

108938

Source:http://linkedlifedata.com/resource/pubmed/id/108938

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1979-7-25
pubmed:abstractText
A trial of daily short courses (6 months) chemotherapy of previously untreated cases of pulmonary tuberculosis in Nigerians was carried out, using two regimens containing rifampicin. All patients had sputum conversion at 3 months, with over 90% of them being sputum-negative at 2 months. There was evidence of radiographic clearance in all the patients at 6 months. It is suggested that patients who still had extensive radiographic lesions at 6 months, though bacteriologically sterile, should have their chemotherapy extended to 9 months to reduce the chance of developing a bacteriological relapse. It was observed that the addition of streptomycin did not make any important contribution to the therapeutic success of rifampicin-isoniazid regimen. No bacteriological relapse was encountered 3 months after the cessation of chemotherapy. Rifampicin was well tolerated and toxic reactions were virtually non-existent. This study confirms the efficacy of short course regimens containing rifampicin. The regimen is advocated, especially in areas where patients' co-operation at taking the 18 month standard treatment cannot be guaranteed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0309-3913
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-81
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1978
pubmed:articleTitle
Daily short course (6 months) chemotherapy for treatment of pulmonary tuberculosis in Nigerians: a preliminary report.
pubmed:publicationType
Journal Article